These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 16750496

  • 21. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
    Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM, PRIME II investigators.
    Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
    [Abstract] [Full Text] [Related]

  • 22. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
    Sedlmayer F, Zehentmayr F, Fastner G.
    Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775
    [Abstract] [Full Text] [Related]

  • 23. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
    Poortmans PM, Collette L, Bartelink H, Struikmans H, Van den Bogaert WF, Fourquet A, Jager JJ, Hoogenraad W, Müller RP, Dubois JB, Bolla M, Van Der Hulst M, Wárlám-Rodenhuis CC, Pierart M, Horiot JC, EORTC Radiation Oncology and Breast Cancer Groups.
    Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
    [Abstract] [Full Text] [Related]

  • 24. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [Abstract] [Full Text] [Related]

  • 25. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F.
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [Abstract] [Full Text] [Related]

  • 26. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
    Polgár C, Fodor J, Major T, Sulyok Z, Kásler M.
    Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
    [Abstract] [Full Text] [Related]

  • 27. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
    Livi L, Meattini I, Franceschini D, Saieva C, Meacci F, Marrazzo L, Gerlain E, Desideri I, Scotti V, Nori J, Sanchez LJ, Orzalesi L, Bonomo P, Greto D, Bianchi S, Biti G.
    Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
    [Abstract] [Full Text] [Related]

  • 28. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.
    J Natl Cancer Inst; 2005 Jan 19; 97(2):116-26. PubMed ID: 15657341
    [Abstract] [Full Text] [Related]

  • 29. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY, Jung SY, Lee S, Kang HS, Lee ES, Park IH, Lee KS, Ro J, Lee NK, Shin KH.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1037-42. PubMed ID: 24267970
    [Abstract] [Full Text] [Related]

  • 30. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
    Fastner G, Sedlmayer F, Merz F, Deutschmann H, Reitsamer R, Menzel C, Stierle C, Farmini A, Fischer T, Ciabattoni A, Mirri A, Hager E, Reinartz G, Lemanski C, Orecchia R, Valentini V.
    Radiother Oncol; 2013 Aug 01; 108(2):279-86. PubMed ID: 23830467
    [Abstract] [Full Text] [Related]

  • 31. Perioperative brachytherapy for pretreated chest wall recurrence of breast cancer.
    Mayer A, Naszály A, Patyánik M, Zaránd P, Polgár I, Klinkó T.
    Strahlenther Onkol; 2002 Nov 01; 178(11):633-6. PubMed ID: 12426674
    [Abstract] [Full Text] [Related]

  • 32. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy.
    Fodor J, Major T, Polgár C, Tóth J, Németh G.
    Neoplasma; 2000 Nov 01; 47(3):181-6. PubMed ID: 11043843
    [Abstract] [Full Text] [Related]

  • 33. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    EORTC Breast Cancer Cooperative GroupDepartment of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands. n.bijker@nki.nl, EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.
    J Clin Oncol; 2006 Jul 20; 24(21):3381-7. PubMed ID: 16801628
    [Abstract] [Full Text] [Related]

  • 34. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.
    Kontos M, Allen DS, Agbaje OF, Hamed H, Fentiman IS.
    Eur J Surg Oncol; 2011 Dec 20; 37(12):1051-8. PubMed ID: 21843919
    [Abstract] [Full Text] [Related]

  • 35. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
    Barbieri V, Sanpaolo P, Genovesi D.
    Clin Breast Cancer; 2011 Apr 20; 11(2):114-20. PubMed ID: 21569997
    [Abstract] [Full Text] [Related]

  • 36. Long-term results of hypofractionated radiation therapy for breast cancer.
    Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C.
    N Engl J Med; 2010 Feb 11; 362(6):513-20. PubMed ID: 20147717
    [Abstract] [Full Text] [Related]

  • 37. Hypofractionated radiation therapy for early stage breast cancer: outcomes, toxicities, and cost analysis.
    Min C, Connolly E, Chen T, Jozsef G, Formenti SC.
    Breast J; 2014 Feb 11; 20(3):267-73. PubMed ID: 24750510
    [Abstract] [Full Text] [Related]

  • 38. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.
    Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, Weir LM, Olivotto IA.
    N Engl J Med; 2004 Sep 02; 351(10):963-70. PubMed ID: 15342804
    [Abstract] [Full Text] [Related]

  • 39. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C, Fodor J, Orosz Z, Major T, Takácsi-Nagy Z, Mangel LC, Sulyok Z, Somogyi A, Kásler M, Németh G.
    Strahlenther Onkol; 2002 Nov 02; 178(11):615-23. PubMed ID: 12426672
    [Abstract] [Full Text] [Related]

  • 40. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.
    Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, Peckitt C, Reise S, Ross G, Sharp G, Symonds-Tayler R, Tait D, Yarnold J, Breast Technology Group.
    Radiother Oncol; 2007 Mar 02; 82(3):254-64. PubMed ID: 17224195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.